摘要
目的：观察复方丹参注射液腹腔内注射联合腹水超滤回输治疗肝硬化难治性腹水的疗效及安全性。方法：将100例随机分为两组，治疗组采用复方丹参注射液腹腔内注射联合腹水超滤回输治疗，对照组单用腹水超滤回输治疗；比较两组临床疗效。结果：治疗组疗效明显优于对照组。结论：采用复方丹参注射液腹腔内注射联合腹水超滤回输治疗肝硬化难治性腹水安全有效。
Objective： To observe the effect and security of treating cirrhosis with refractory ascites by Fufang Danshen injection plus ascites ultrafiltration reinfusion. Methods： Randomly divide 100 patients into treatment group and control group, taking Fufang Danshen injection plus ascites ultrafiltration reinfusion therapy in treatment group, taking the ascites ultrafiltration reinfusion therapy in control group; Compare the clinical effect of two group. Result： Effects of the treatment group is better than the control. Conclusion： Taking Fufang Danshen injection plus ascites ultrafiltration reinfusion treating cirrhosis with refractory ascites have a good effects.
出处
《中医临床研究》
2010年第13期65-66,共2页
Clinical Journal Of Chinese Medicine
关键词
肝硬化
腹水
腹水超滤回输
复方丹参注射液
Cirrhosis
Ascites
Ascites ultrafiltration reinfusion
Fufang Danshen injection
